Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antibiotic and antimicrobial agents > Nafcillin sodium salt monohydrate
Nafcillin sodium salt monohydrate
Inquiry
| Post Date: | May 29,2014 |
| Expiry Date: | May 29,2015 |
| Detailed Description: |
Cas No. :7177-50-6
Quantity: 10Metric Tons Name Nafcillin sodium salt monohydrate Synonyms Sodium (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate Molecular Formula C21H21N2NaO5S.H2O Molecular Weight 454.47 CAS Registry Number 7177-50-6 |
| CAS Registry Number: | 7177-50-6 |
| Synonyms: | ;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2-ethoxy-1-naphthalenyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2S-(2alpha,5alpha,6beta));Monosodium (2S,5R,6R)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate;Nafcil;Nafcillin natrium-1-wasser;UNII-49G3001BCK;Wy 3277;4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2-ethoxy-1-naphthalenyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2S-(2alpha,5alpha,6beta))-;Nafcillin sodium salt monohydrate;sodium (2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate; |
| Molecular Formula: | C21H23N2NaO6S |
| Molecular Weight: | 454.4719 |
| Molecular Structure: | 
|
| Company: | Jinan Chuan Cheng Pharmaceutical R&D Co., Ltd. [ China ] |
| Contact: | Libor |
| Tel: | +86-531-88821598 |
| Fax: | +86-531-88902485 |
| Email: | ccpharma@163.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
